[{"Assets_0_Q3_USD":"4185728000.0","CIK":"12208","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"0.92","EarningsPerShareBasic_3_Q3_USD":"1.51","EarningsPerShareDiluted_1_Q3_USD":"0.91","EarningsPerShareDiluted_3_Q3_USD":"1.49","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","Market Cap":"16656203893.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"34531000.0","NetIncomeLossConverted_1_Q3_USD":"27393000.0","NetIncomeLossConverted_3_Q3_USD":"44841000.0","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","RevenuesConverted_1_Q3_USD":"535003000.0","RevenuesConverted_3_Q3_USD":"1539720000.0","SP500":"SP500","Sector":"Capital Goods","StockholdersEquity_0_Q3_USD":"2848447000.0","Ticker":"BIO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"30052000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"29994000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"29660000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"29618000.0","filed":"20171109","footnote":null,"form":"10-Q","fp":"Q3","fy":"2017.0","name":"BIO RAD LABORATORIES INC","period":"20170930","qtrs":"0","uom":"USD"}]